Vineet laboratories Limited has reported a significant turnaround in its Q3FY26 financial performance, posting a net profit of ₹85.07 lakh compared to a substantial loss of ₹570.70 lakh in the corresponding quarter of the previous fiscal year. The pharmaceutical company's Board of Directors approved these unaudited standalone financial results for the quarter and nine months ended December 31, 2025, during their meeting held on February 14, 2026.

Board Meeting Outcomes and Regulatory Compliance

The Board meeting, which commenced at 11:30 AM and concluded at 3:40 PM on February 14, 2026, addressed multiple strategic decisions beyond financial result approval. The company has submitted its quarterly results under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to both BSE Limited (Scrip Code: 543298) and National Stock Exchange of India Limited (Scrip Code: VINEETLAB).

Financial Performance Overview

The company's quarterly financial metrics demonstrate a mixed performance with profitability recovery despite revenue challenges:

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Vineet Laboratories achieved remarkable improvement in profitability:

Equipment Investments and Strategic Approvals

The Board ratified advances and approved payments to vendors for Quality Control equipment and Purified RO Water equipment made in February 2026. These investments are designated for installation in the company's new production facility, which was previously mentioned in the Rights Issue Letter of Offer dated December 17, 2025. The equipment purchases represent strategic investments in expanding manufacturing capabilities.

Auditor Review and Compliance

NSVR & Associates LLP, the company's statutory auditors, issued an unqualified review report on the quarterly results. The financial results have been prepared in accordance with Indian Accounting Standards and comply with SEBI regulations. The results are available on the company's website at www.vineetlabs.co.in and on BSE and NSE platforms for stakeholder access.

Vineet Laboratories Limited successfully concluded its Extra-Ordinary General Meeting on February 07, 2026, with shareholders providing overwhelming support for a key board appointment. The meeting, conducted through video conferencing from 11:00 AM to 11:45 AM, focused on a single special resolution regarding the appointment of an Independent Director.

Meeting Overview and Participation

The EGM was held in compliance with regulatory requirements under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. With a record date of January 30, 2026, the company had 10106 total shareholders eligible to participate.

The meeting witnessed participation from 51 shareholders through video conferencing, including 12 from the promoter and promoter group category and 39 from the public category. No shareholders attended the meeting in person or through proxy.

Resolution Details and Voting Results

The sole agenda item was a special resolution for the appointment of Ms. Jasmin Kunal Tailor (DIN: 10794164) as an Independent Director of the company. The promoter and promoter group were not interested in this particular resolution, ensuring independent decision-making by shareholders.

E-Voting Process and Scrutinizer Report

The voting process was conducted electronically through Central Depository Services Limited (CDSL) platform. Remote e-voting was available from February 04, 2026, at 09:00 AM to February 06, 2026, at 05:00 PM, followed by e-voting facility during the EGM for eligible shareholders.

Mr. Jineshwar Kumar Sankhala from P S Rao & Associates served as the scrutinizer for the meeting. He was appointed by the Board of Directors on January 07, 2026, and submitted his report on February 07, 2026, confirming the validity and transparency of the voting process.

Resolution Outcome

The special resolution was passed with overwhelming support, receiving 1219216 votes in favor representing 99.99% of total valid votes cast. Only 78 votes were cast against the resolution, representing 0.01% of the total. The strong approval rate demonstrates shareholder confidence in the proposed appointment.

The voting results and scrutinizer's report have been made available on the company's website at www.vineetlabs.co.in and on CDSL's e-voting portal at www.evotingindia.com , ensuring transparency and regulatory compliance.